Strainsforpains, Inc.
EBYH · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.27 | 0.97 | -0.07 | 0.30 |
| FCF Yield | 0.00% | -1.50% | 0.00% | -2.23% |
| EV / EBITDA | -248.46 | -373.47 | -250.00 | 249.15 |
| Quality | ||||
| ROIC | -1.05% | -0.75% | -1.24% | 0.92% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 1.00 | 3.23 | -0.76 | -2.68 |
| Growth | ||||
| Revenue 3-Year CAGR | 78.41% | 189.96% | 218.04% | 217.02% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 22.76% |
| Safety | ||||
| Net Debt / EBITDA | -110.00 | -153.93 | -92.96 | 124.84 |
| Interest Coverage | -0.61 | -0.44 | -0.72 | 0.54 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 6,711.97 | 2,919.55 | 2,887.07 | 673.65 |